Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model.
Hits::

![]()
Institution:基础医学院
Title of Paper:Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model.
Journal:Cardiovasc Drugs Ther
First Author:张铭湘
All the Authors:260101120097,张铭湘,ql00791
Document Code:lw-151690
Volume:11
Issue:20
Translation or Not:No
Date of Publication:2013-11
Release Time:2019-10-24